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Introduction
Melatonin is a neurohormone synthesized and released
from the pineal gland at night in all vertebrate animals
tested to date. The nocturnal synthesis of melatonin is
activated by dramatic increases in pineal serotonin
N-acetyltransferase (or arylalkylamine N-aceyltransferase;
AANAT) activity, which is stimulated by the adrenergic
signaling from the superior cervical ganglia and controlled
by the central circadian pacemaker in the brain [1]. When
the adrenergic signaling is terminated by light at night,
melatonin release declines rapidly with associated decrease
in AANAT protein content [2, 3]. How AANAT is
degraded is not fully understood.
Earlier studies demonstrate that the threonine residue at
the 29th position (T29; T31 in sheep) is phosphorylated in
vivo in the night at pineal gland, and the phosphorylation is
associated with increased AANAT protein content [4].
Upon phosphorylation at the T29 residue, AANAT inter-
acts with 14-3-3 proteins, which leads to the stabilization of
AANAT protein in vitro [5]. Accordingly, mutations that
affect either AANAT phosphorylation at the T29 position
or a subsequent interaction with 14-3-3 would affect
AANAT protein stability in vivo. Recent studies from
our laboratory demonstrate that the H28Y mutation affects
the ability of the phosphorylated AANAT-H28Y mutant to
interact with 14-3-3 [6]. Additionally, studies have shown
that AANAT isolated from the night pineal gland is tightly
associated with 14-3-3 and is phosphorylated at the T31
position (equivalent to the T29 residue in rat) in sheep
AANAT [5]. These studies demonstrate that AANAT
phosphorylation and its subsequent interaction with 14-3-
3 is a key event in stabilization of AANAT protein in vivo.
While phosphorylation and subsequent interaction with
14-3-3 increase AANAT protein levels, proteasomal activ-
ities dramatically reduce AANAT protein. When pineal
cells are stimulated in vitro with a combination of beta-
adrenergic activator and inhibitor, AANAT activity and
protein levels are low compared with those stimulated with
the activators alone [2]. When proteasome inhibitor is
added, the drug prevents the decrease in AANAT protein
and activity (when assayed in broken cell extracts) elicited
by the beta-adrenergic inhibitor [2]. In flow through
cultures of rat retinae, light-induced suppression of mela-
tonin release and AANAT activity is prevented by co-
incubation with a proteasome inhibitor [7]. These studies
demonstrate that proteasome proteolysis of AANAT is one
mechanism responsible for light-induced suppression of
AANAT protein (and activity) and melatonin formation.
The amino acid residues in AANAT that are targeted by
the proteasome machinery are not defined.
Ubiquitin-mediated proteasomal degradation comprises
the major proteolytic pathway in eukaryotes. Proteins
targeted for degradation by this pathway are conjugated by
ubiquitin chains to lysines via a complex cascade [8]. In
addition to the canonical lysine ubiquitination, cysteines
can also be targeted for ubiquitination in a few reported
cases [9, 10]. Moreover, the N-terminus of a protein can
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also be tagged by an ubiquitin chain [9]. Studies have shown
that when the amino acids targeted by the ubiquitin chains
are removed or mutated to other residues, the resultant
proteins can be markedly stabilized and no longer subjected
to the proteasome degradations. Furthermore, many pro-
teins with short lives are degraded via the N-end role
pathway [10], which relates the in vivo half-life of a protein
to the identity of its N-terminal residue. The destabilizing
residues at the N-terminus of short-lived proteins include
leucine, phenylalanine, tyrosine, etc., whose substitutions to
serine, alanine or other smaller residues stabilize the protein
[11].
To define residues important for proteasomal degrada-
tion of AANAT, we have expressed rat AANAT proteins in
HEK 293 cells from both wildtype and mutant AANAT
constructs and analyzed their protein content with or
without the proteasome inhibitor, MG132. Our results
strongly suggest that the N-terminus of AANAT mediates
the proteasomal degradation of AANAT protein.
Materials and methods
Animals
All animal protocols were reviewed and approved by the
University of Michigan animal care and use committee.
Adult inbred PVG rats (Harlan, Indianapolis, IN, USA)
were used in this study. Animals were housed in temper-
ature-controlled chambers with a light and dark cycle of
12:12 hr (lights on at 6 hr).
In vivo measurement of melatonin release using
pineal microdialysis
Rats were implanted with pineal microdialysis probes [12].
Following a recovery period of 1 day, animals were placed
in microdialysis chambers. Microdialysis was performed
with artificial CSF solution flowing continuously at 2 lL/
min. The pineal dialysates were collected in a sample loop
of an automated injector (Instech, Plymouth Meeting, PA,
USA), which delivers samples into an HPLC column
(Sigma, St Louis, MO, USA) at 10 min intervals with the
aid of an HPLC pump (Shimadzu, Tokyo, Japan). Frac-
tionated pineal dialysates were analyzed online by a
fluorescence detector. The automated control of the HPLC
system including the handling and storage of the chroma-
tograms were carried out with an external computer using
Shimadzu chromatography software [12].
A light pulse of 10 min was given to rats on the third day
of online microdialysis 4 hr into the darkness (22:00–
22:10 hr) in the presence or absence of drug infusion.
Isoproterenol (ISO, 1 lm), MG132 (1 or 10 lm), or vehicle
(DMSO) was individually infused into the pineal gland of
rats for 4 hr (20:00–2:00 hr) prior to the light pulse.
Cell culture, mutagenesis, transfection, and treatment
The detailed method on the generation of AANAT
expressing plasmid can be found elsewhere [13]. Constructs
with lysine mutations all contain a C-terminal myc epitope
[14]. Point mutation was made using a QuikChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA).
N-terminal truncation of AANAT was made using PCR
method. All mutant constructs were confirmed by sequenc-
ing before transfection. HEK 293 cells were seeded in 24-
well plates at 70% confluency. Plasmid constructs were
transfected the next day using Lipofectamine 2000 (Invi-
trogen, Carlsbad, CA, USA) according to the manufac-
tures recommendation. One day after transient
transfection, or 24 hr following splitting of the stably trans-
fected cells, carbobenzoxy-l-leucyl-l-leucinal (MG132;
Sigma), or vehicle (DMSO) was added to the media for
indicated amount of time.
Western blot analysis
The pineal glands were collected from rats left in the
darkness or exposed to light for 10 min (22:00–22:10 hr)
and sacrificed at 23:00 hr in the dark. Total proteins from
either the pineal glands, or AANAT transfected (transient
or stable) cells were extracted and separated by electro-
phoresis and transferred to a nitrocellulose membrane. The
membrane was blocked with 5% nonfat dry milk in TBS-T
solution (20 mm Tris–HCl, pH 7.5, 140 mm NaCl, and
0.05% Tween-20), and hybridized with anti-AANAT (gen-
erated in our lab, see [13]), anti-myc (generous gift from Dr.
Jeremy Nathans), and anti-14-3-3 (Cat# K-19 from Santa
Cruz, Santa Cruz, CA, USA) antibodies. The secondary
antibodies used include: IRDye 700- and IRDye 800-
conjugated anti-rabbit or anti-mouse IgG antibodies (LI-
COR Biosciences, Lincoln, NE, USA). The infrared signals
were detected by the Odyssey Image System and analyzed
by the Odyssey software (LI-COR Biosciences, Lincoln,
NE, USA).
Generation of HEK 293 cell lines stably expressing
rAANAT
HEK 293 stable cell lines were made essentially as described
[3]. HEK 293 cells were grown in DMEM containing 10%
fetal bovine serum and 1% penicillin/streptomycin in a
humidified 5% CO2 incubator at 37C. Cells at 80–90%
confluency were transfected with AANAT plasmids (rat
AANAT wt coding fragments cloned in pCS2 vector;
0.9 mg per well of a 24-well plate) mixed individually with a
puromycin resistance plasmid (0.1 mg) using Lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA). The transfected
cells were split 24 hr later at a 1:10 dilution into two 10-cm
plates. Puromycin (2 mg/mL) was added to the media the
following day and incubation continued for 14 additional
days until colonies were detected with naked eyes. Cells in
each clone were transferred to a well in a 24-well plate using
cloning cylinders and trypsin. Two to three days later,
AANAT expression level of these closes was examined
using Western blot. The clones that had highest level of
expression were selected for experiments in this paper.
AANAT activity measurement in intact cells
Cells stably expressing AANAT, 2 days after reseeding,
were incubated with either MG132 (1 lm) or vehicle
(DMSO) overnight. 5-methoxytryptamine (5-MT, 1 lm)
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was then added to the tissue culture cells for 4 hr, which is
converted to melatonin (released into the tissue culture
supernatant) by AANAT in the stable cells. Tissue culture
supernatant was collected for melatonin measurement using
HPLC coupled with a fluorescence detector.
Results
In order to obtain a precise timing of melatonin and
AANAT protein suppression by light at night, a group
(n = 5) of inbred PVG rats were analyzed using online
microdialysis for multiple days. Prior to the light pulse,
melatonin levels increased to the maximum levels at
21:40 hr, stayed at the peak levels for 7 hr, and began to
decline at 5:00 hr (Fig. 1A). A light pulse given at 22:00 hr
(white dashed line), resulted in an immediate suppression of
melatonin secretion, which reached its minimum levels
within 20 min and stayed at that levels for about 2 hr.
Melatonin secretion was recovered to its nocturnal high
levels 4 hr following the end of the light pulse (at 22:10 hr).
In all tested rats, melatonin secretion was the lowest during
22:30–23:30 hr following a 10-min light pulse at 22:00 hr
(Fig. 1A).
AANAT protein levels in the same strain of rats showed
dramatic decrease following the light pulse of 10 min from
rats sacrificed at 23:00 hr (Fig. 1B). This level represents
the minimum amount of AANAT protein contents follow-
ing the light pulse in this strain of rats.
Since the nightly production of melatonin is the result of
adrenergic stimulation of the pineal gland, we tested the
ability of an exogenously infused adrenergic agonist,
isoproterenol (ISO), to antagonize the action of light on
melatonin release in vivo. When the pineal gland was
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Fig. 1. Effects of light pulses at night on melatonin secretion and serotonin N-acetyltransferase (AANAT) protein levels in vivo. Melatonin
secretion during each cycle was normalized to the maximum value of each night. Each data point represents the amount of melatonin in
pineal dialysates during a 10-min collection (20 lL of dialysates). The shaded gray areas represent the dark period (18:00–6:00 hr). (A) In
vivo circadian profile of melatonin secretion from five rats without (solid dots) and with (white filled dots) light pulses (22:00–22:10 hr).
Each color represents one rat. The 10-min light pulse, marked by a white dashed line, was given on day 3 of the microdialysis. (B) The effect
of a single light pulse (10 min) at night on AANAT protein levels in rats. Two rats housed in LD 12:12 hr were exposed to a single light
pulse for 10 min (22:00–22:10 hr, lights off at 18:00 hr), while two control rats were kept in the darkness without light exposure. All rats
were sacrificed at 23:00 hr in the dark. Pineal protein extracts from rats without the light pulse (left two lanes) or with the light pulse (right
two lanes) were loaded in each lane (one-fifth of a single pineal for each lane) and analyzed for expression levels of AANAT (top panel) and
14-3-3 (bottom panel) proteins. AANAT protein content was dramatically reduced following the light pulse. (C) Isoproterenol (ISO) given
prior to light exposure is sufficient to prevent light-induced suppression of melatonin secretion in vivo. Melatonin secretion from a single rat
was followed for three consecutive days. Blue tracings indicate the melatonin secretion patterns under normal conditions (LD 12:12 hr) on
day 1. On day 2 (pink tracings), 1 lm of ISO was infused into the rat pineal gland for 6 hr (20:00–2:00 hr) and a 10-min light pulse was given
at 22:00 hr (marked by a pink dashed line). Light-induced suppression of melatonin was prevented by ISO. On day 3 (yellow tracings), a
light pulse was given (time marked as yellow dashed line) without the infusion of ISO, and there was a dramatic suppression of melatonin
secretion similar as shown in panel A. These results were confirmed in more than five rats. (D) MG132 did not prevent the light-induced
suppression of melatonin secretion. On day 1 (blue tracings), no infusion and no light pulse at night were given. On day 2 (red tracings),
MG132 (1 lm), from 20:00–2:00 hr was infused into the rat pineal. A light pulse was given at 22:00–22:10 hr (red dashed line), and there was
a dramatic suppression of melatonin secretion. Identical results were obtained in at least three rats with this dose and in four rats with 10 lm
MG132 (data not shown).
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light-induced suppression of melatonin was completed
prevented (Fig. 1C).
Inhibition of proteasome activity was shown previously
to block the effect of light on AANAT degradation in
pineal organ culture [2] and to prevent light-induced
melatonin suppression in retina cultures [7]. We therefore
tested the ability of a proteasome inhibitor in prevention of
light-induced suppression of melatonin secretion in freely
moving rats. In contrast to ISO (Fig. 1C), MG132 (1 and
10 lm), a potent cell permeable inhibitor of proteasome,
was unable to prevent the light-induced suppression of
melatonin secretion in vivo (Fig. 1D).
To further understand mechanisms of AANAT protein
regulation, we generated cell lines stably expressing rat
AANAT protein and stimulated cells with various drugs.
When cells were exposed to either phorbal 12-myristate 13-
acetate (PMA), which stimulates protein kinase C (PKC),
or forskolin (FSK), which elevates the intracellular levels of
cAMP by activation of adenylyl cyclase, AANAT protein
levels were clearly elevated (Fig. 2A). When AANAT-
expressing cells were exposed to MG132, AANAT protein
levels were dramatically elevated in a duration dependent
manner (Fig. 2B), confirming that the proteasome activity
regulates AANAT protein degradation.
To understand why MG132 failed to prevent the light-
induced suppression of melatonin secretion in vivo, we
tested AANAT activity in intact cells stably expressing
AANAT in the presence of MG132. MG132 incubation of
the AANAT-expressing cells resulted in an abundant
accumulation of AANAT protein, with high molecular
weight bands that might represent ubiquitinated proteins
(Fig. 3A). When MG132-treated live cells were tested for
AANAT activity, however, there was only a moderate
increase in AANAT enzyme activity compared to the
control cells without the inhibitor (Fig. 3B). When the
AANAT activity was normalized by the amount of protein
elevated by the proteasome inhibition, the AANAT enzyme
activity was markedly reduced (8% of the control levels)
per unit of expressed protein (Fig. 3C).
To define the amino acid residues in AANAT that are
important for proteasome proteolysis of AANAT, we
performed a series of site-directed mutagenesis. Four lysine
residues are found in rat AANAT and are relatively
conserved in mammalian AANAT protein sequences [15].
Each lysine was mutated to arginine singly or in combina-
tions. When the lysine mutants were tested in HEK 293
cells in a Western analysis, no detectable changes of their
protein levels were found for any of the mutant constructs,
compared with the wildtype (Fig. 4A). Wildtype (wt), K8R
(lysine at amino acid position #8 was mutated to arginine),
and lysine-less (K0) mutants (in which all four lysines were
replaced with arginine), all of which were tagged with myc
epitope [14] at the C-terminus, were transiently expressed in
HEK 293 cells and were exposed to MG132 for 24 hr.
Lysine-less mutant (K0) as well as K8R mutant displayed
MG132 dependent elevation of protein contents to a similar
extent as wildtype AANAT protein (Fig. 4B).
Reports indicate that, in some protein, the ubiquitination
can occur on the cysteine residues [9]. Of the 10 cysteine
residues found in rat AANAT, 6 cysteines (C37, C61, C75,
C158, C177, and C191) were conserved across all mamma-
lian species examined [15]. Of these, two (C37 and C61)
were found on the surface of the crystal structure [16].
When they were mutated to alanine, their expression levels
(Fig. 5A) as well as their sensitivity to MG132 (Fig. 5B)
were unchanged from the wildtype AANAT.
A series of truncation mutations were generated that
deleted 30 (not shown), 10, 5, 4 (not shown), 3 (not shown),
and 2 amino acids from the N-terminus of AANAT, and
were expressed individually in HEK 293 cells (Fig. 6). All
N-terminal truncation mutants displayed higher levels of
mutant proteins compared with wildtype. When cells
expressing these mutants were exposed to MG132, no
further protection was evident compared to the wildtype
AANAT protein.
The common feature among all truncation mutants was
the absence of the leucine residue at the second position
(L2). In fact, the amino acid residues from all other
mammalian AANAT proteins at the same position are all
bulky residues (proline, tryptophan, or asparagines, in
addition to leucine). Unlike rat AANAT, which is com-
posed of 205 amino acids, most other mammalian AANAT
proteins are composed of 207 amino acids with additional
dipeptides such as MS (methionine and serine) or MP
(methionine and proline) added to their N-terminus [15].
Moreover, 9 out of the 11 AANAT proteins with the length
of 207 amino acids contain serine at its second position
(S2). To clarify the role of S2, a smaller amino acid
compared with L2, in AANAT stability, we added MS to
the N-terminus of rat AANAT and tested their sensitivity
to MG132. Addition of a smaller amino acid ahead of the
L2 did not alter the sensitivity of the mutant protein to
MG132 compared to the wildtype AANAT (Fig. 6).
Discussion
AANAT is a key enzyme in synthesis of melatonin, a
hormone with many physiological roles [17–21]. Melatonin
+ MG132– MG132








Fig. 2. Serotonin N-acetyltransferase (AANAT) protein content
can be increased via kinase activation or proteasome inhibition in
vitro. (A) PKA and PKC activators (PMA and FSK) increased the
content of the AANAT protein. HEK 293 cells stably expressing
AANAT were split into a 24-well plate, and stimulated with PMA
(1 lm), FSK (10 lm) or DMSO (control) for 4 hr, then subjected
to Western blot analysis for AANAT (upper panel), or 14-3-3 (low
panel) protein content. (B) AANAT levels increase dramatically
upon MG132 administration. HEK 293 cells stably expressing
AANAT were stimulated with MG132 (1 lm) for different periods
of time and then subjected to Western blot for analysis of AANAT
protein level. AANAT protein levels increased with stimulation by
MG132. Each experiment was repeated in triplicate.
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synthesis and AANAT activity are well known to be
sensitive to light at night, due to the rapid degradation of
AANAT protein by the proteasome [2]. As the proteasome
proteolysis begins with ubiquitination on a specific amino
acid residue on a target protein, it is important to clarify the
identity of the amino acid residues involved in AANAT
degradation. In this paper, we have performed a series of
mutagenesis analysis of rat AANAT and identified the N-
terminus as the critical region controlling the proteasomal
degradation of AANAT.
While many studies have examined the kinetics of
melatonin suppression by light, very few studies followed
melatonin secretion in the same animal before and after the
light pulse at high resolution and correlated that with
AANAT protein levels. Our studies, using the pineal
microdialysis technique [12], demonstrate that following a
light pulse of 10 min, melatonin secretion was suppressed to
less than 50% of maximum levels within 20 min and stayed
at minimum levels for more than 80 min in all animals.
Importantly, our study was performed in freely behaving
inbred rats with minimum inter-individual differences in
their melatonin secretion profiles [22] and consequently
showed little variation in their response to light. These
results increased our confidence in using individual rats in
analysis of AANAT protein expression, which showed
dramatic suppression following a 10-min light pulse.
Importantly, even when melatonin secretion was at its
minimum following the light pulse, AANAT protein was
still found at detectable levels when compared to its
daytime levels. At early night, this amount of AANAT
protein was sufficient to ensure near maximum levels of
melatonin production in our previous studies [23]. These
results suggest that AANAT degradation alone may not
account fully for the precipitous decline of melatonin
secretion by light.
Light pulses at night suppress melatonin secretion by
terminating the release of norepinephrine from the superior
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Fig. 3. The proteasome inhibitor MG132 increased serotonin N-acetyltransferase (AANAT) protein content without associated increase in
enzyme activity. (A) HEK 293 cells stably expressing AANAT were stimulated with MG132 for 24 hr, and then subjected to Western blot
using AANAT antibody (cells incubated with vehicle DMSO served as control). The AANAT protein content increased dramatically, with
smearing of the upper bands. (B) The increase in AANAT protein content did not accompany corresponding increase in AANAT enzyme
activity. AANAT protein content following MG132 incubation increased by 21-fold compared with the control (right columns). AANAT
activity assayed in intact cells increased by 1.6-fold. (C) The enzyme activity of AANAT (normalized by the amount of protein) is much
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Fig. 4. Lysine residues do not contribute to the proteasomal deg-
radation of serotonin N-acetyltransferase (AANAT). (A) Lysine
mutants are expressed at similar levels as AANAT wildtype. Each
of the four lysine residues found in rat AANAT were mutated to
arginine singly or in combinations. All lysine mutants, as well as
the wt AANAT constructs, containing a C-terminal myc tag, were
transfected into HEK 293 cells, and subjected to Western blot
analysis after 48 hr to determine the AANAT protein levels. There
was no detectable change in the AANAT protein level for any of
the lysine mutants. (B) The sensitivity of the lysine-less AANAT
protein to MG132 is similar to that of wildtype AANAT. Wildtype
(wt), K8R (lysine at amino acid position #8 was mutated to argi-
nine), and a lysine-less (K0) mutant (all four lysines were replaced
with arginine) were transiently transfected into HEK 293 cells and
were exposed to10 lm MG132 or DMSO for 24 hr. The elevation
of protein content after exposure to MG132 in K8R and K0 mu-
tants is similar to the wildtype AANAT protein. Each experiment










Fig. 5. Mutation of surface cysteine residues does not affect the
stability of serotonin N-acetyltransferase (AANAT) or its response
to MG132. (A) Mutation of the two cysteines (at amino acid
positions #37 and 61), found on the surface of the AANAT crystal
structure, did not alter the mutant protein levels. The cysteine
residues were singly mutated to alanine (C37A and C61A) and were
transiently transfected into HEK 293 cells and subjected to Wes-
tern blot analysis. The protein levels of these cysteine mutants were
similar to the control. (B) The sensitivity of the cysteine mutants to




adrenergic receptors are capable of blocking the effect of
light at night. Our studies performed in the same animal
before and after the light pulse in the presence of drugs
demonstrate that this is indeed the case: direct infusion of
an adrenergic agonist, isoproterenol, into the pineal gland
of a living rat before the light pulse was able to prevent the
suppression of melatonin secretion. Since the rapid
AANAT degradation parallels the precipitous decline of
melatonin secretion and is due to proteasomal proteolysis,
we anticipated that melatonin suppression by light could be
prevented in vivo by blocking the proteasome activity. To
our surprise, MG132 was unable to block the light-induced
suppression of melatonin secretion, despite the use of
multiple different doses that were all effective in blocking
AANAT protein degradation in tissue culture cells. Our
data contradict with those performed in cultured retinae,
which showed that suppression of proteasome activity
could restore melatonin secretion in retina cultures [7].
To understand degradation mechanisms of AANAT, we
generated stable cell lines expressing rat AANAT in HEK
293 cells. Drugs that activate the signaling pathways (PKC
by PMA and PKA by FSK), which are stimulated in vivo
by norepinephrine release at night, markedly elevated
AANAT protein expression in these cells. Moreover,
inhibition of the proteasome activity by MG132 resulted
in a dramatic increase of AANAT protein levels in a time
dependent manner. When live cells with accumulated
AANAT protein were assayed for AANAT enzyme activ-
ity, however, the increase in activity was barely significant.
In contrast with the 21-fold increase in AANAT protein
content in the presence of MG132, a merely 1.6-fold
increase of activity was detected. Thus, the accumulated
AANAT protein expressed only 8% of the enzyme activity
per unit of protein compared with controls that were
treated with the vehicle (DMSO). These results from the
live tissue culture cells support our in vivo findings
described above, which shows that inhibition of proteasome
activity was unable to suppress light-induced inhibition of
melatonin secretion. It remains to be determined whether
similar results can be obtained with other cell permeable
proteasome inhibitors besides MG132.
Since lysine is the canonical ubiquitination site on target
protein for the proteasomal degradation [8], we tested each
of the four lysines present in rat AANAT. Mutation of
lysine to arginine singly, in pairs, or altogether caused no
change in the stability of the mutant AANAT protein.
Furthermore, the sensitivity of the lysine-less AANAT
mutant protein to the inhibitor of the proteasome was
unchanged compared to the wildtype AANAT. These
results demonstrate strongly that AANAT degradation by
the proteasome is independent of the lysine residues.
In addition to the canonical lysine ubiquitination, pro-
teasome degradation pathway can also target cysteine
residues [24, 25]. To examine the role of cysteine residues
in AANAT degradation, we mutated two of the conserved
cysteines found on the surface of the protein structure [16]
that are most likely to be accessed by the proteasome
machinery. Mutations of either one of the cysteines resulted
in no change in protein levels when expressed in HEK 293
cells, and no alteration was found in their sensitivity to
proteasome inhibitors compared with wildtype AANAT
protein. These results suggest that the two surface cysteine
residues, C37 and C61, do not contribute to the proteaso-
mal proteolysis of AANAT.
In addition to the pathways described above, proteaso-
mal proteolysis is also achieved via the N-end-rule pathway
[11], which is an ubiquitin-dependent proteolytic system
where ubiquitin ligases (N-recognins) bind to type 1 and
type 2 destabilizing N-terminal residues of protein sub-
strates [26]. The type 1 residues include basic amino acids
such as lysine, arginine, etc., whereas the type 2 residues
include bulky hydrophobic amino acids such as leucine,
tryptophan, and tyrosine [26]. On the other hand, smaller
residues such as serine or alanine are considered to be the
stabilizing amino acids at corresponding positions. To test
the role of the N-terminus in AANAT degradation, we
performed a series of deletion analysis from its N-terminus
that removed the first 30, 20, 10, 5, 4, 3, and 2 amino acids.
All truncated AANAT proteins were markedly stabilized
when expressed in HEK 293 cells and became insensitive to
proteasome inhibition. The common feature among all
deletion mutations was the absence of the leucine residue at
the second position from the N-terminus, which is a bulky
hydrophobic amino acid considered to be one of the type 2
destabilizing residues in the N-end role pathway [26]. These
results strongly suggest that AANAT degradation follows
the N-end rule pathway of proteasomal proteolysis and the
leucine 2 is important in this process.
As serine is considered to be the stabilizing N-terminal
residue, and is found at the N-terminus of many mamma-
lian AANAT proteins including human, sheep and degu
[15], we added Met-Ser (MS) dipeptide to the N-terminus of
rat AANAT. The resultant mutant protein, 207 amino
acids in length, contained MSML in its N-terminus, which
is similar to that of Monkey and Degu AANAT proteins
that contain MSMQ at the N-terminal ends [15]. The
mutant protein, despite possessing a stabilizing serine at
position 2, behaved like rat AANAT in its low expression
and responsiveness to proteasome inhibition when ex-
pressed in HEK 293 cells. These studies suggest that: (i)





Fig. 6. The N-terminal residues of AANAT are important for the
stability of the protein. A series of N-terminal truncation mutants
were made by deletion of the first 30, 20, 10 (T10), 5 (T5), 4, 3, and
2 (T2) amino acids. The truncated mutants with an engineered
methionine residue at its N-terminus were transiently transfected
into HEK 293 cells and exposed to 10 lm of MG132 for 24 hr (no
exposure served as control). Cells were collected and subjected to
Western blot analysis for AANAT protein content. The protein
content of all truncated mutants was much higher than that of the
wildtype AANAT, and treatment with MG132 made little differ-
ence in the protein content of the mutants. When methionine and
serine residues were added to the N-terminus of wildtype rat AA-
NAT (+MS), the expression levels of the mutant protein was
comparable to the wildtype rat AANAT. Furthermore, the MS-
mutant responded to MG132 in a similar manner as wildtype
AANAT protein. This experiment was repeated in triplicate.
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serine at position #2 may not always be the stabilizing
residue in the N-end rule pathway or (ii) the key destabi-
lizing residue in the N-end rule pathway can be close to, but
not necessarily at the very N-terminus of a short lived
protein. It remains to be determined how AANAT from
other species is degraded with serine in their N-termini.
Furthermore, the appropriate context surrounding the
destabilizing N-terminal resides in AANAT remains to be
explored in future studies.
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